Good Distribution Practice (GDP) for Medical Cannabis

GDP bridges manufacturer and patient. For medical cannabis, it carries specific traceability, temperature, and security requirements.

Context and Why It Matters

Operating to pharmaceutical standard reorders business priorities. Consistency, traceability, and quality discipline weigh as much as grams per square meter.

Evidence and Current Practice

Technical decisions made in cultivation, post-harvest, and packaging determine not only unit cost but the batch's eligibility for regulated markets. Each step must be defensible on paper.

Operational Considerations

Commercial relationships with pharmaceutical buyers rest on audits, quality agreements, and rapid response to deviations. Operational transparency is competitive advantage, not weakness.

Bottom Line

Investing early in data systems—from QMS to seed-to-sale traceability—lowers total cost of compliance and accelerates entry into international supply chains.